Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
AVEO Pharmaceuticals
Pharma
Hengrui, Sanofi and Aslan—Fierce Pharma Asia
Hengrui got an FDA warning letter. Sanofi invests in its global capacity center in India. Singapore biotech Aslan Pharma winds down.
Angus Liu
Jul 19, 2024 9:48am
BMS' Opdivo, Aveo's Fotivda fail as combo in kidney cancer
Jul 18, 2024 4:26pm
Korean company LG Chem buys Aveo oncology drugs for $566M
Oct 18, 2022 10:17am
Aveo's tivozanib, after years of setbacks, wins its FDA nod
Mar 11, 2021 11:25am
Former Aveo CFO found guilty of misleading investors
Nov 21, 2018 11:05am
